Implication of stem cells in the biology and therapy of head and neck cancer
- PMID: 22558051
- PMCID: PMC3341578
- DOI: 10.3205/cto000074
Implication of stem cells in the biology and therapy of head and neck cancer
Abstract
The progress which has been made in the therapy of patients with head and neck cancer in recent years mainly concern the HPV associated HNSCC and the quality of life. The overall survival of patients carrying non HPV associated HNSCC during the last thirty years has not experienced any significant improvement and must be referred to as static [1], [2]. The problem of the illness remains unchanged in the frequent and poorly controllable relapse situation. The locoregionally originating tumours or lymph node metastases show a considerably poorer response towards current therapies. Likewise for a number of patients a formation of distant metastases seems to develop during the course of the illness. Those distant metastases are also therapeutically rather difficult to control. Therefore the mortality of the non HPV induced head and neck cancer remains unchanged. The term "stem cell" describes the entity cell, which acts as a reservoir for new cells in order to replace defective or necrotic cells. A fundamental characteristic of stem cells is the constant ability to multiply into different type of cells, which subsequently do not proliferate. With the insight of new knowledge within the regenerative medicine and the ability of stem cells of self regenerating proliferation and their multipotency in the differentiation, the origin of cancer attains a new distinction. If you look on the tumour as a malignant wound it becomes obvious, that the regeneration or the composition of additional tissue depends on the presence and differentiation of stem cells. The wound healing, which is a regeneration of tissue depends not only on stationary stem cells. In fact stem cells are attracted for "homing" in the defective areas by despatch of various messengers, which then form and replace the vascular tree or other tissue [3], [4].Next to those stem cells, which functionally help to form tumour tissue, a small entity of "real cancer stem cells" in solid tumours is expected. Those occur in tumours and they have typical stem cell characteristics like self-regeneration and the potential of differentiation and are potentially responsible for tumour growth. With their ability of self-regeneration they would have the ability to form a complete tumour out of every single cell. That tumour would histologically look like the tumour those cells initially originated from. Of particular interest regarding those currently still elusive cancer stem cells is their resistance towards current therapies like radiotherapy or chemotherapy. Those insights now get a completely new meaning in tumour biology: Does a cancer stem cell exist, which is able to initiate and keep up tumour growth despite all possible therapeutic interventions? This presentation will outline the current views regarding cancer stem cells in non HPV associated HNSCC and it will highlight problems, which are currently researched on. The objective must be to understand the biology of those cells in a way that make an extended range of therapeutics possible. A therapy, which specifically targets cancer stem cells, could improve the chances of recovery.
Keywords: CD34; WNT pathway; cancer stem cells; head and neck squamous cell cancer (HNSCC); self renewal; stem cells.
Figures
Similar articles
-
Wnt/β-catenin signalling maintains self-renewal and tumourigenicity of head and neck squamous cell carcinoma stem-like cells by activating Oct4.J Pathol. 2014 Sep;234(1):99-107. doi: 10.1002/path.4383. Epub 2014 Jul 23. J Pathol. 2014. PMID: 24871033
-
Evaluation of the cancer stem cell marker DCLK1 in patients with lymph node metastases of head and neck cancer.Pathol Res Pract. 2019 Dec;215(12):152698. doi: 10.1016/j.prp.2019.152698. Epub 2019 Oct 23. Pathol Res Pract. 2019. PMID: 31706685
-
INGN 201: Ad-p53, Ad5CMV-p53, adenoviral p53, p53 gene therapy--introgen, RPR/INGN 201.Drugs R D. 2007;8(3):176-87. doi: 10.2165/00126839-200708030-00005. Drugs R D. 2007. PMID: 17472413 Review.
-
HPV Infection of the Head and Neck Region and Its Stem Cells.J Dent Res. 2015 Nov;94(11):1532-43. doi: 10.1177/0022034515605456. Epub 2015 Sep 9. J Dent Res. 2015. PMID: 26353884 Review.
-
Activation of Matrix Hyaluronan-Mediated CD44 Signaling, Epigenetic Regulation and Chemoresistance in Head and Neck Cancer Stem Cells.Int J Mol Sci. 2017 Aug 24;18(9):1849. doi: 10.3390/ijms18091849. Int J Mol Sci. 2017. PMID: 28837080 Free PMC article. Review.
Cited by
-
Is small smarter? Nanomaterial-based detection and elimination of circulating tumor cells: current knowledge and perspectives.Int J Nanomedicine. 2019 Jun 6;14:4187-4209. doi: 10.2147/IJN.S198319. eCollection 2019. Int J Nanomedicine. 2019. PMID: 31289440 Free PMC article. Review.
-
The role of piRNA and its potential clinical implications in cancer.Epigenomics. 2015;7(6):975-84. doi: 10.2217/epi.15.37. Epub 2015 May 1. Epigenomics. 2015. PMID: 25929784 Free PMC article. Review.
-
Nano Meets Micro-Translational Nanotechnology in Medicine: Nano-Based Applications for Early Tumor Detection and Therapy.Nanomaterials (Basel). 2020 Feb 22;10(2):383. doi: 10.3390/nano10020383. Nanomaterials (Basel). 2020. PMID: 32098406 Free PMC article. Review.
References
-
- Leemans CR, Tiwari R, Nauta JJ, van der Waal I, Snow GB. Recurrence at the primary site in head and neck cancer and the significance of neck lymph node metastases as a prognostic factor. Cancer. 1994;73(1):187–190. doi: 10.1002/1097-0142(19940101)73:1<187::AID-CNCR2820730132>3.0.CO;2-J. Available from: http://dx.doi.org/10.1002/1097-0142(19940101)73:1<187::AID-CNCR282073013.... - DOI - DOI - PubMed
-
- Greenlee RT, Hill-Harmon MB, Murray T, Thun M. Cancer statistics, 2001. CA Cancer J Clin. 2001;51(1):15–36. doi: 10.3322/canjclin.51.1.15. Available from: http://dx.doi.org/10.3322/canjclin.51.1.15. - DOI - DOI - PubMed
-
- Young MR, Kolesiak K, Wright MA, Gabrilovich DI. Chemoattraction of femoral CD34+ progenitor cells by tumor-derived vascular endothelial cell growth factor. Clin Exp Metastasis. 1999;17(10):881–888. doi: 10.1023/A:1006708607666. Available from: http://dx.doi.org/10.1023/A:1006708607666. - DOI - DOI - PubMed
-
- Young MR. Tumor skewing of CD34+ progenitor cell differentiation into endothelial cells. Int J Cancer. 2004;109(4):516–524. doi: 10.1002/ijc.20003. Available from: http://dx.doi.org/10.1002/ijc.20003. - DOI - DOI - PubMed
-
- Reers S, Hagge AC, Pries R, Wollenberg B. Profiling of potential stem cell marker proteins in HNSCC. 2011:submitted.
LinkOut - more resources
Full Text Sources